Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT01521845

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Shahid Beheshti University of Medical Sciences (from the registry)
Registry
  • NCT NCT01521845
Other papers using this trial's data
  • Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I? Cardiovascular therapeutics, 2013-10 DOI, PubMed 23134549

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Iran (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01521845. Randomized; single masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2012-07-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
Condition
Coronary Arteriosclerosis
Intervention (Drug)
omega 3
Lead sponsor
Shahid Beheshti University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct01521845
Content hash
21b939334a23d087cbd2893b16ec606230c1f3c11341ec70f85a7f012ee5b438